<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04430465</url>
  </required_header>
  <id_info>
    <org_study_id>D225</org_study_id>
    <nct_id>NCT04430465</nct_id>
  </id_info>
  <brief_title>Effects of Wholegrains on Children's Health (KORN)</brief_title>
  <official_title>Effects of Wholegrains on Children's Health (KORN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chalmers University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      KORN investigates the effects of wholegrain oat and rye intake on health and cognitive
      wellbeing in children with overweight.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of KORN is to investigate the effects of wholegrain oat and rye intake on
      cardiometabolic health in slightly overweight 8-13-year-old children. Moreover, KORN aims to
      investigate effects on body weight and body composition, inflammatory markers,
      gastrointestinal wellbeing and cognitive function and explore the potential underlying
      mechanisms through assessment of changes in the children's gut microbiota as well as
      potential genotype-dependent and sex-specific effects.

      The study has a randomized controlled cross-over design. In two 8-week dietary periods the
      children will receive grain products (cereals, breads, pasta etc) with either high or low
      content of wholegrain from oat and rye in random order. Measurements and biological sampling
      will be performed at 0, 8 and 16 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The intervention and data collection will be conducted unmasked. The data set will be masked before data analysis by staff not involved in the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Low density lipoprotein cholesterol</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>16 weeks</time_frame>
    <description>by stadiometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>16 weeks</time_frame>
    <description>by digital scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index z-score</measure>
    <time_frame>16 weeks</time_frame>
    <description>by height and weight measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>16 weeks</time_frame>
    <description>by measuring tape</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass index</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat free mass index</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>16 weeks</time_frame>
    <description>by digital device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>16 weeks</time_frame>
    <description>by digital device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>16 weeks</time_frame>
    <description>by digital device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycosylated hemoglobin (HbA1c)</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triacylglycerol</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High density lipoprotein cholesterol</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High sensitivity C-reactive protein</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attention</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by d2 test of attention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inhibition</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by Stroop color and word test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Processing speed</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by d2 test of attention and Stroop color and word test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working memory</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by Kim's game</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Socio-emotional skills</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by parent reported Strengths and Difficulties Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool consistency</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by the Bristol stool scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal wellbeing</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of overweight</measure>
    <time_frame>16 weeks</time_frame>
    <description>By the International Obesity Task Force criteria</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Dietary intake</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by 4-day dietary record</description>
  </other_outcome>
  <other_outcome>
    <measure>Physical activity</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Sociodemographic characteristics</measure>
    <time_frame>at baseline</time_frame>
    <description>assessed by questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Pubertal development stage</measure>
    <time_frame>at baseline</time_frame>
    <description>assessed by the Tanner scales</description>
  </other_outcome>
  <other_outcome>
    <measure>General satisfaction</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Liking of study products</measure>
    <time_frame>16 weeks</time_frame>
    <description>assessed by questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Alkylresorcinols (compliance)</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Android fat mass index</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Gynoid fat mass index</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Android:gynoid fat mass ratio</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Immune cell count</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Interleukin 6 (IL-6)</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Interleukin 1β (IL-1β)</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Tumor necrosis factor alpha (TNFα)</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Bone Mineral Content</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Bone area</measure>
    <time_frame>16 weeks</time_frame>
    <description>by Dual-energy X-ray Absorptiometry</description>
  </other_outcome>
  <other_outcome>
    <measure>Gut microbiome composition determined by high throughput sequencing and qPCR</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fecal sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Short chain fatty acids</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Short chain fatty acids</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fecal sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Bile acids</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Bile acids</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fecal sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Fatty acid composition</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>C-peptide</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Epigenetics</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolomics</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolomics</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fecal sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Proteomics</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Proteomics</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fecal sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Genotypes</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Adiponectin</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Leptin</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Appetite hormones</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Testosterone</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Estrogen</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <other_outcome>
    <measure>Gonadotropins</measure>
    <time_frame>16 weeks</time_frame>
    <description>by fasting blood sample</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Cardiometabolic Health</condition>
  <condition>Gastro-intestinal Wellbeing</condition>
  <condition>Cognitive Function</condition>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>High wholegrain then low wholegrain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starting with high wholegrain intervention followed by low wholegrain intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low wholegrain then high wholegrain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starting with low wholegrain intervention followed by high wholegrain intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grain products high in wholegrains from oat and rye</intervention_name>
    <description>A selection of grainproducts high in wholegrain from oat and rye, including cereals, bread, rolls, and pasta is replacing habitual grain products</description>
    <arm_group_label>High wholegrain then low wholegrain</arm_group_label>
    <arm_group_label>Low wholegrain then high wholegrain</arm_group_label>
    <other_name>Wholegrain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Grain products low in wholegrains</intervention_name>
    <description>A selection of grainproducts low in wholegrain, including cereals, bread, rolls, and pasta is replacing habitual grain products</description>
    <arm_group_label>High wholegrain then low wholegrain</arm_group_label>
    <arm_group_label>Low wholegrain then high wholegrain</arm_group_label>
    <other_name>Refined grain</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Boys and girls 8-13 years of age

          -  Be overweight i.e. have a parent-reported BMI of at least +1 standard deviation above
             the median according to the age and sex-standardized Danish growth curves

          -  Be healthy

          -  Like grain products and eat them daily

          -  Speak Danish in order to understand the study procedures

          -  At least one parent must read and speak Danish, in order to be properly informed about
             the study procedures

          -  Parents must have freezer capacity for 2 weeks bread provision

        Exclusion Criteria:

          -  Allergy or intolerance to the study foods, including gluten

          -  Use of dietary fiber supplements (e.g. HUSK) or probiotic supplements

          -  Dieting or on a special diet

          -  Serious chronic illnesses and diseases that may interfere with study outcomes

          -  Use of medication that may affect study outcomes, including use of antibiotics the
             last month

          -  Concomitant participation in other studies involving dietary supplements, drugs or
             blood sampling

          -  Living in a household with another participating child
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Camilla T Damsgaard, PhD</last_name>
    <phone>35332221</phone>
    <phone_ext>+45</phone_ext>
    <email>ctd@nexs.ku.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie TB Madsen, MSc</last_name>
    <phone>35324058</phone>
    <phone_ext>+45</phone_ext>
    <email>mtbm@nexs.ku.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nutrition, Exercise and Sports, University of Copenhagen</name>
      <address>
        <city>Frederiksberg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 10, 2020</study_first_submitted>
  <study_first_submitted_qc>June 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Camilla Trab Damsgaard</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Wholegrain</keyword>
  <keyword>Cardiovascular risk markers</keyword>
  <keyword>Overweight</keyword>
  <keyword>Adolescents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

